Tag Archive for LifeVantage

LifeVantage Reports $45.4 Million Q1 Fiscal 2016

 
LifeVantage Corporation today reported financial results for its first quarter ended September 30, 2015.
First Quarter Fiscal 2016 Highlights:

Revenue was flat at $45.4 million when compared sequentially to $45.3 million for the fourth fiscal quarter of 2015;
Revenue in the Americas increased 3.0% and revenue in Asia/Pacific decreased 8.2% on a sequential basis;
Adjusted EBITDA increased 43% to $4.5 million, compared to $3.1 million in the fourth fiscal quarter of 2015;
Net income was $1.1 million which includes approximately $1.1 million of pretax executive transition costs;
Ended the quarter with $13.7 million in cash and reduced long-term debt by $3.1 million to $18.5 million;
Executed on strategic growth plan including launch of a new product and announced plan for expansion into the European Union.

“Our first quarter results were in-line with our expectations and reflect stability in our revenue

Read more...

LifeVantage Launches TrueScience Micro Lift Serum

 
LifeVantage Corporation (Nasdaq: LFVN), has launched TrueScience Micro Lift Serum for immediate distribution in the United States.
The TrueScience Micro Lift Serum is a natural way to instantly diminish the look of crow’s feet, baggy skin, and dark circles around the eyes.
In as little as 3 minutes, it visibly tightens, smooths, and firms the skin around the eyes, quickly restoring a youthful looking radiance without sacrificing long-term skin health.
The TrueScience Micro Lift Serum pairs with the revolutionary TrueScience™ Skin Care system and is only available from LifeVantage.

“Customers today expect instant results from the products they use,” said LifeVantage President and Chief Executive Officer Darren Jansen.

“Our TrueScience Micro Lift Serum is in alignment with our strategy of offering demonstrable and effective products. It’s the ideal companion to our TrueScience skin

Read more...

LifeVantage Expanding Into European Union

 
LifeVantage Corporation (Nasdaq: LFVN), announced today it would expand its operations and distributor network into the European Union beginning with the United Kingdom and the Netherlands.
The company intends to begin conducting business-building meetings within the two countries in February 2016.
According to the World Federation of Direct Selling Associations (WFDSA), the European Union represented nearly $33 billion in retail sales in 2014. LifeVantage is taking a deliberate approach to international market expansion, and both the United Kingdom and Netherlands play a critical role for the company to successfully expand into the European Union.
“It is our intent that these are the first of many launches into the European Union countries,” said LifeVantage President and Chief Executive Officer, Darren Jensen.
“The United Kingdom represents one of the fastest growing markets within the Direct Selling

Read more...

LifeVantage Presents True Science Skincare Regimen at IFSCC Conference

 
LifeVantage Corporation, announced today that Nathalie Chevreau, PhD, Senior Vice President of Research and Development, presented two poster abstracts describing the innovative aspects of TrueScience skin care regimen at the 2015 International Federation of Societies of Cosmetic Chemists Conference in Zurich, Switzerland.
Dr. Chevreau presented the anti-aging effect of the TrueScience skin care regimen through gene modulation in the skin layers, as well as a treatment of intrinsic and extrinsic aging.  Visible and measurable clinical outcomes can be attributed to the unique Nrf2 ingredients extensive anti-aging efficacy and reversal of cellular stress and DNA damage.
The International Federation of Societies of Cosmetic Chemists (IFSCC) is a worldwide federation dedicated to international cooperation in cosmetic science and technology.  Currently 47 Societies representing 57 countries are members. Individual membership now exceeds 15,000.

“IFSCC is the highest platform

Read more...

LifeVantage Announces 2015 Revenues Of $190.3 Million

 
LifeVantage Corporation today reported financial results for its fourth quarter and full year ended June 30, 2015.
Fourth Quarter Fiscal 2015 Highlights:

Revenue was flat at $45.3 million when compared sequentially to $45.2 million for the third fiscal quarter of 2015;
Revenue in the Americas increased 2.5% and revenue in Asia/Pacific decreased 5.5% on a sequential basis;
Adjusted EBITDA decreased to $3.1 million, compared to $3.3 million in the third fiscal quarter of 2015;
Completed implementation of annual cost structure improvements of approximately $4 million.  
  

Full Year Fiscal 2015 Highlights:

Revenue was $190.3 million compared to $214.0 million for the prior fiscal year;
Revenue in the Americas decreased 2.2% and revenue in Asia/Pacific decreased 28.2% compared to the prior fiscal year;
Adjusted EBITDA was $17.4 million compared to $24.5 million for the prior year;
Reduced long-term debt to $20.7 million at

Read more...

LifeVantage Appoints New Chief Financial Officer

 
LifeVantage Corporation announced today that Mark Jaggi has been appointed Chief Financial Officer for the company effective August 24, 2015. 
Mr. Jaggi is a highly experienced finance and operations executive, having spent the past 20 years in lead financial, operational, and strategic planning roles. Most recently, Mr. Jaggi served as Chief Financial Officer at TwinLab Consolidated Holdings, where he led and supported their debt and equity financing, as well as the financial and operational decision-making in all areas of the business.
Prior to TwinLab Consolidated Holdings, Mr. Jaggi served as Chief Executive Officer and Chief Financial Officer at Summit Industries, a manufacturer and marketer of pharmaceutical and non-regulated liquid and cream solutions. Prior to Summit Industries, Mr. Jaggi was Chief Financial Officer at O’Sullivan Industries, where he led the international financial processes including analysis, accounting

Read more...

Lifevantage Prelim Annual Revenues $190 Million

 
Lifevantage announced preliminary results for the fourth quarter and full year ended June 30, 2015.
For the fourth fiscal quarter ended June 30, 2015, the Company expects to report revenue of approximately $45 million, compared to $56 million for the same period of fiscal 2014. The change in revenue was primarily due to a decline in revenue from Japan. Operating income for the fourth quarter of 2015 was $1.5 million, compared to $4.7 million in the fourth fiscal quarter of 2014.
For the full fiscal year ended June 30, 2015, the Company expects to report revenue of approximately $190 million, compared to $214 million in fiscal 2014. Operating income for full fiscal year 2015 was $13.9 million, compared to $19.5 million in the prior year period.
During the full year of fiscal 2015, the Company

Read more...

LifeVantage Launches Sports Science Lab

 
LifeVantage Corporation  has announced the launch of the LifeVantage Sport Science Lab at Real Salt Lake. The LifeVantage Sports Science Lab is designed to measure and assess the player’s response to training stress. This joint venture will be housed within Rio Tinto Stadium and all testing will be conducted by the Real Salt Lake Sports Science Department under the direction of Dan Barlow, Director of Sports Science and Performance for Real Salt Lake. 

“By monitoring the player’s individual responses to training stress, the Sports Science Team at Real Salt Lake can more closely adjust workout and recovery regimens, cellular stress profiles, and nutrition and supplement interventions,” said Shawn Talbott, PhD., Chief Science Office at LifeVantage Corporation. “Their ability to benchmark and measure oxidation, inflammation and biochemistry within the cellular stress profiles of their players

Read more...

LifeVantage Q3 Revenues $43 Million

 
LifeVantage Corporation (Nasdaq:LFVN) today reported financial results for its third quarter and nine months ended March 31, 2015.
Third Quarter Fiscal 2015 Highlights:

Revenue was $45 million compared to $55 million in the prior year period;
Revenue in the Americas increased by 1% compared to the prior year period;
Adjusted EBITDA was $3.3 million, compared to $5.7 million in the prior year period;
Identified annual cost structure savings of approximately $4 million.

Dave S. Manovich, Executive Vice Chairman of LifeVantage stated, “We are very pleased with our recently announced appointment of Darren Jensen as our next President and Chief Executive Officer. Throughout the transition to a new CEO, we have focused on taking the necessary steps to help us reignite top and bottom line growth. We have identified approximately $4 million in annual cost reductions.  Approximately $1.3 million

Read more...

LifeVantage Names Darren Jensen as CEO

 
LifeVantage Corporation (Nasdaq:LFVN), announced today that Darren Jensen has been named President and Chief Executive Officer for the company.
Mr. Jensen’s appointment is effective May 18, 2015..

“LifeVantage is uniquely positioned as one of the leading product-driven business opportunities available,” said Jensen. “I am honored and delighted to work together with our independent distributors to execute our vision of bringing that opportunity to the world.”

Jensen brings 25 years of global network marketing and direct selling experience to LifeVantage from companies selling a variety of product types including nutritional supplements and personal care products.

“Darren Jensen is a well-known and a respected visionary leader in the global network marketing and direct selling industry,” said Garry Mauro, Chairman of the Board of Directors for LifeVantage Corporation. “The Board quickly recognized that Darren’s unparalleled track record of

Read more...